Bioengineers and medical researchers at the University of Pennsylvania have designed a proof-of-concept microfluidic device containing 128 mixing channels working in parallel. The channels mix a precise amount of lipid and mRNA, crafting individual lipid nanoparticles on a miniaturized assembly line. The researchers tested the lipid nanoparticles produced by their device in a mouse study, showing that they could deliver therapeutic mRNA sequences with four-to-five times greater activity than those made by conventional methods.
An official website of the United States government.